Have a personal or library account? Click to login
Ambulatory Patients with Cardiometabolic Disease and Without Evidence of COVID-19 During the Pandemic. The CorCOVID LATAM Study Cover

Ambulatory Patients with Cardiometabolic Disease and Without Evidence of COVID-19 During the Pandemic. The CorCOVID LATAM Study

Global Heart
Volume 16 (2021): Issue 1
By: Ricardo Lopez Santi,  Manlio F. Márquez,  Daniel Piskorz,  Clara Saldarriaga,  Alberto Lorenzatti,  Fernando Wyss,  Alexander Valdés Martín,  Jorge Sotomayor Perales,  Jean Carrion Arcela,  Elirub de Lourdes Rojas Gimon,  Gustavo Sambadaro,  Gonzalo Emanuel Perez,  Ivan Mendoza,  Fernando Lanas,  Roberto Flores,  Alvaro Sosa Liprandi,  Bryce Alexander and  Adrian Baranchuk  
Open Access
|Feb 2021

References

  1. 1Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020; 395: 497–506. DOI: 10.1016/S0140-6736(20)30183-5
    Back to article
  2. 2MacIntyre CR, Wang Q. Physical distancing, face masks, and eye protection for prevention of COVID-19 [published correction appears in Lancet. 2020 Jun 5]. Lancet. 2020; 395(10242): 1950–51. DOI: 10.1016/S0140-6736(20)31183-1
    Back to article
  3. 3Bauch CT, Anand M. COVID-19: When should quarantine be enforced? [published online ahead of print, 2020 May 20]. Lancet Infect Dis. 2020; S1473-3099(20)30428-X. DOI: 10.1016/S1473-3099(20)30428-X
    Back to article
  4. 4Brooks SK, Webster RK, Smith LE, et al. The psychological impact of quarantine and how to reduce it: Rapid review of the evidence. Lancet. 2020; 395: 912–20. DOI: 10.1016/S0140-6736(20)30460-8
    Back to article
  5. 5Boukhris M, Hillani A, Moroni F, et al. Cardiovascular implications of the COVID-19 Pandemic: A global perspective. Can J Cardiol. 2020; 36(7): 1068–80. DOI: 10.1016/j.cjca.2020.05.018
    Back to article
  6. 6Pessoa-Amorim G, Camm CF, Gajendragadkar P, et al. Admission of patients with STEMI since the outbreak of the COVID-19 pandemic: A survey by the European Society of Cardiology. Eur Heart J Qual Care Clin Outcomes. 2020; 6(3): 210–16. DOI: 10.1093/ehjqcco/qcaa046
    Back to article
  7. 7Burki TK. Cancer care in the time of COVID-19. Lancet Oncol. 2020; 21(5): 628. DOI: 10.1016/S1470-2045(20)30201-1
    Back to article
  8. 8Korytkowski M, Antinori-Lent K, Drincic A, et al. A pragmatic approach to inpatient diabetes management during the COVID-19 pandemic. J Clin Endocrinol Metab. 2020; 105(9): dgaa342. DOI: 10.1210/clinem/dgaa342
    Back to article
  9. 9Day AT, Sher DJ, Lee RC, et al. Head and neck oncology during the COVID-19 pandemic: Reconsidering traditional treatment paradigms in light of new surgical and other multilevel risks. Oral Oncol. 2020; 105: 104684. DOI: 10.1016/j.oraloncology.2020.104684
    Back to article
  10. 10Bhaskar S, Bradley S, Israeli-Korn S, et al. Chronic Neurology in COVID-19 Era: Clinical Considerations and Recommendations From the REPROGRAM Consortium. Front Neurol. 2020; 11: 664. Published 2020 Jun 24. DOI: 10.3389/fneur.2020.00664
    Back to article
  11. 11Chalasani M, Nasir K, Gupta MD, Kalra A. The Covid-19 pandemic and India’s cardiovascular disease burden: Finding the right balance [published online ahead of print, 2020 May 15]. Indian J Med Ethics. 2020; V(3): 1–3. DOI: 10.20529/IJME.2020.059
    Back to article
  12. 12Pinilla-Roncancio M. The reality of disability: Multidimensional poverty of people with disability and their families in Latin America. Disabil Health J. 2018; 11(3): 398–404. DOI: 10.1016/j.dhjo.2017.12.007
    Back to article
  13. 13Holmes EA, O’Connor RC, Perry VH, et al. Multidisciplinary research priorities for the COVID-19 pandemic: a call for action for mental health science. Lancet Psychiatry. 2020; 7(6): 547–60. DOI: 10.1016/S2215-0366(20)30168-1
    Back to article
  14. 14Brook RD, Levy P, Rajagopalan S. Cardiometabolic risk factor control during times of crises and beyond. Circ Cardiovasc Qual Outcomes. 2020; 13(7): e006815. DOI: 10.1161/CIRCOUTCOMES.120.006815
    Back to article
  15. 15Santi RL, Piskorz DL, Marquez MF, et al. Impact of the pandemic on non-infected cardiometabolic patients. A survey in countries of Latin America rationale and design of CorCOVID LATAM Study [published online ahead of print, 2020 Aug 28]. CJC Open. 2020. DOI: 10.1016/j.cjco.2020.08.007
    Back to article
  16. 16World Health Organization. Global Recommendations on Physical Activity for Health. https://www.who.int/publications/i/item/9789241599979 (Last visit 09/dec/2020).
    Back to article
  17. 17Brook RD, Levy P, Rajagopalan S. Cardiometabolic risk factor control during times of crises and beyond. Circ Cardiovasc Qual Outcomes. 2020; 13(7): e006815. DOI: 10.1161/CIRCOUTCOMES.120.006815
    Back to article
  18. 18Tam CF, Cheung KS, Lam S, et al. Impact of coronavirus disease 2019 (COVID-19) outbreak on ST-segment-elevation myocardial infarction care in Hong Kong, China. Circ Cardiovasc Qual Outcomes. 2020; 13(4): e006631. DOI: 10.1161/CIRCOUTCOMES.120.006631
    Back to article
  19. 19Huet F, Prieur C, Schurtz G, et al. One train may hide another: Acute cardiovascular diseases could be neglected because of the COVID-19 pandemic. Arch Cardiovasc Dis. 2020; 113(5): 303–07. DOI: 10.1016/j.acvd.2020.04.002
    Back to article
  20. 20American Heart Association. Cardiovascular disease risk reduction across healthcare settings: A scientific statement from the American Heart Association [published online ahead of print, 2020 Aug 7]. Circ Cardiovasc Qual Outcomes. 2020; HCQ0000000000000094. DOI: 10.1161/HCQ.0000000000000094
    Back to article
  21. 21Julien HM, Eberly LA, Adusumalli S. Telemedicine and the forgotten America. Circulation. 2020; 142(4): 312–14. DOI: 10.1161/CIRCULATIONAHA.120.048535
    Back to article
  22. 22Curioso WH. Building capacity and training for digital health: Challenges and opportunities in Latin America. J Med Internet Res. 2019; 21(12): e16513. Published 2019 Dec 18. DOI: 10.2196/preprints.16513
    Back to article
  23. 23Novillo-Ortiz D, Dumit EM, D’Agostino M, et al. Digital health in the Americas: Advances and challenges in connected health. BMJ Innov. 2018; 4(3): 123–27. DOI: 10.1136/bmjinnov-2017-000258
    Back to article
  24. 24Kowitt SD, Cornacchione Ross J, Jarman KL, et al. Tobacco quit intentions and behaviors among cigar smokers in the United States in response to COVID-19. Int J Environ Res Public Health. 2020; 17(15): 5368. Published 2020 Jul 25. DOI: 10.3390/ijerph17155368
    Back to article
  25. 25Giral P, Neumann A, Weill A, Coste J. Cardiovascular effect of discontinuing statins for primary prevention at the age of 75 years: A nationwide population-based cohort study in France. Eur Heart J. 2019; 40(43): 3516–25. DOI: 10.1093/eurheartj/ehz458
    Back to article
  26. 26Sundström J, Hedberg J, Thuresson M, Aarskog P, Johannesen KM, Oldgren J. Low-Dose aspirin discontinuation and risk of cardiovascular events: A Swedish Nationwide, population-based cohort study. Circulation. 2017; 136(13): 1183–92. DOI: 10.1161/CIRCULATIONAHA.117.028321
    Back to article
  27. 27Booth JN 3rd, Colantonio LD, Chen L, et al. Statin discontinuation, reinitiation, and persistence patterns among medicare beneficiaries after myocardial infarction: A cohort study. Circ Cardiovasc Qual Outcomes. 2017; 10(10): e003626. DOI: 10.1161/CIRCOUTCOMES.117.003626
    Back to article
  28. 28Castellano JM, Sanz G, Peñalvo JL, et al. A polypill strategy to improve adherence: Results from the FOCUS project. J Am Coll Cardiol. 2014; 64(20): 2071–82. DOI: 10.1016/j.jacc.2014.08.021
    Back to article
  29. 29Khatib R, McKee M, Shannon H, Chow C, Rangarajan S, Teo K, et al. Availability and affordability of cardiovascular disease medicines and their effect on use in high-income, middle-income, and low-income countries: An analysis of the PURE study data. Lancet. 2016; 387(10013): 61–9. DOI: 10.1016/S0140-6736(15)00469-9
    Back to article
  30. 30Cannata F, Chiarito M, Reimers B, et al. Continuation versus discontinuation of ACE inhibitors or angiotensin II receptor blockers in COVID-19: Effects on blood pressure control and mortality [published online ahead of print, 2020 Jun 5]. Eur Heart J Cardiovasc Pharmacother. 2020; pvaa056. DOI: 10.1093/ehjcvp/pvaa056
    Back to article
  31. 31Danser AHJ, Epstein M, Batlle D. Renin-Angiotensin system blockers and the COVID-19 pandemic: At present there is no evidence to abandon renin-angiotensin system blockers. Hypertension. 2020; 75(6): 1382–85. DOI: 10.1161/HYPERTENSIONAHA.120.15082
    Back to article
  32. 32Zhang X, Yu J, Pan LY, Jiang HY. ACEI/ARB use and risk of infection or severity or mortality of COVID-19: A systematic review and meta-analysis. Pharmacol Res. 2020; 158: 104927. DOI: 10.1016/j.phrs.2020.104927
    Back to article
  33. 33Wang C, Pan R, Wan X, et al. Immediate psychological responses and associated factors during the initial stage of the 2019 coronavirus disease (COVID-19) epidemic among the general population in China. Int J Environ Res Public Health. 2020; 17(5): 1729. Published 2020 Mar 6. DOI: 10.3390/ijerph17051729
    Back to article
  34. 34Cao W, Fang Z, Hou G, et al. The psychological impact of the COVID-19 epidemic on college students in China. Psychiatry Res. 2020; 287: 112934. DOI: 10.1016/j.psychres.2020.112934
    Back to article
  35. 35Lima CKT, Carvalho PMM, Lima IAAS, et al. The emotional impact of coronavirus 2019-nCoV (new Coronavirus disease). Psychiatry Res. 2020; 287: 112915. DOI: 10.1016/j.psychres.2020.112915
    Back to article
  36. 36Lazzarino AI, Hamer M, Stamatakis E, Steptoe A. Low socioeconomic status and psychological distress as synergistic predictors of mortality from stroke and coronary heart disease. Psychosom Med. 2013; 75(3): 311–16. DOI: 10.1097/PSY.0b013e3182898e6d
    Back to article
  37. 37Piskorz D, Barragán AP, Santi RL, Vázquez G, Ortiz GS, Zambrano LR, et al. Psychological impact of the pandemic on ambulatory cardiometabolic patients without evidence of SARS-CoV-2 infection. The CorCOVID Latam Psy Study. Curr Probl Cardiol. 2020 Nov 2; 100737. DOI: 10.1016/j.cpcardiol.2020.100737
    Back to article
  38. 38Sumner JA, Khodneva Y, Muntner P, et al. Effects of concurrent depressive symptoms and perceived stress on cardiovascular risk in low- and high-income participants: Findings from the reasons for geographical and racial differences in stroke (REGARDS) Study. J Am Heart Assoc. 2016; 5(10): e003930. DOI: 10.1161/JAHA.116.003930
    Back to article
  39. 39Pierce M, Hope H, Ford T, et al. Mental health before and during the COVID-19 pandemic: a longitudinal probability sample survey of the UK population [published online ahead of print, 2020 Jul 21]. Lancet Psychiatry. 2020; S2215-0366(20)30308-4. DOI: 10.1016/S2215-0366(20)30308-4
    Back to article
  40. 40Lopez Santi R. The development of resilience as behavioral support for chronic disease carriers: Perspectives during COVID-19. J Electrocardiol. 2020 (In Press). DOI: 10.1016/j.jelectrocard.2020.08.018
    Back to article
DOI: https://doi.org/10.5334/gh.932 | Journal eISSN: 2211-8179
Journal RSS Feed
Language: English
Submitted on: Oct 4, 2020
Accepted on: Jan 14, 2021
Published on: Feb 17, 2021
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
Keywords:
Latin America,
COVID-19 pandemic,
cardiovascular disease,
cardiometabolic disease,
social determinants,
SARS-CoV-2

© 2021 Ricardo Lopez Santi, Manlio F. Márquez, Daniel Piskorz, Clara Saldarriaga, Alberto Lorenzatti, Fernando Wyss, Alexander Valdés Martín, Jorge Sotomayor Perales, Jean Carrion Arcela, Elirub de Lourdes Rojas Gimon, Gustavo Sambadaro, Gonzalo Emanuel Perez, Ivan Mendoza, Fernando Lanas, Roberto Flores, Alvaro Sosa Liprandi, Bryce Alexander, Adrian Baranchuk, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.

Previous articleVolume 16 (2021): Issue 1Next article